Stocktoria
Airsculpt Technologies, Inc. AIRS
Nasdaq · XNAS · stock · Services-Offices & Clinics of Doctors of Medicine · website · IPO 2021-10-29
Airsculpt Technologies, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $151.8M | $180.3M | $195.9M | $168.8M | $133.3M |
| SG&A expense | $82.2M | $98.9M | $102.4M | $101.4M | $65.7M |
| Operating income | -$11.6M | -$1.6M | $9.7M | -$4.5M | $15.8M |
| Interest expense | — | — | $6.5M | $6.8M | $4.9M |
| Income tax | -$6.0M | $188,000 | $7.5M | $3.4M | $329,000 |
| Net income | -$11.7M | -$8.0M | -$4.2M | -$14.7M | $10.6M |
| EPS (diluted) | $-0.19 | $-0.14 | $-0.08 | $-0.26 | $-0.01 |
| Operating cash flow | $3.1M | $11.3M | $24.0M | $24.4M | $26.6M |
| Free cash flow | $692,000 | -$2.7M | $14.0M | $11.5M | $19.5M |
| Cash & equivalents | $8.4M | $8.2M | $10.3M | $9.6M | $25.3M |
| Total assets | $187.3M | $212.8M | $204.0M | $200.8M | $200.6M |
| Total liabilities | $99.6M | $134.6M | $120.0M | $130.0M | $117.0M |
| Shareholders' equity | $87.7M | $78.2M | $82.7M | $70.8M | $83.5M |
Source: SEC EDGAR filings · CIK 0001870940 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.